Request Demo
Last update 23 Jan 2025
Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Mesenchymal stem cell therapy |
Synonyms allogenic haMPC therapy Cellular Biomedicine Group, 异体人源脂肪间充质祖细胞（西比曼）, AlloJoin |
Target- |
Mechanism Cell replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
6
Clinical Trials associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)NCT06570291
A Multicenter, Randomized, Double-blind, Controlled Phase III Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells (AlloJoin®) Therapy for Knee Osteoarthritis.
NCT05996224
A Multicenter, Randomized, Double-blind, Controlled Phase III Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells (AlloJoin®) Therapy for Knee Osteoarthritis.
CTR20192352
异体人源脂肪间充质祖细胞注射液（AlloJoin）治疗膝骨关节炎的多中心、随机、双盲、对照II期临床试验
[Translation] A multicenter, randomized, double-blind, controlled phase II clinical trial of allogeneic human adipose-derived mesenchymal progenitor cell injection (AlloJoin) for the treatment of knee osteoarthritis
100 Clinical Results associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
Login to view more data
100 Translational Medicine associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
Login to view more data
100 Patents (Medical) associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
Login to view more data
100 Deals associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoarthritis, Knee | Phase 3 | CN | 12 Jul 2023 | |
| Osteoarthritis, Knee | Phase 3 | CN | 12 Jul 2023 | |
| Pulmonary Disease, Chronic Obstructive | Preclinical | CN | 02 Jun 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free